Anderson Schock
Stock Analyst at B. Riley Securities
(1.72)
# 3,040
Out of 4,355 analysts
34
Total ratings
46.7%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Reiterated: Buy | $18 | $10.23 | +75.95% | 4 | May 28, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $3.91 | +155.75% | 1 | May 18, 2026 | |
| ELMD Electromed | Maintained: Buy | $38 → $40 | $37.72 | +6.04% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Maintained: Buy | $11 → $10 | $5.19 | +92.68% | 4 | May 13, 2026 | |
| TCMD Tactile Systems Technology | Upgraded: Buy | $32 → $36 | $24.61 | +46.28% | 4 | May 7, 2026 | |
| BEAT HeartBeam | Initiated Coverage: Buy | $4 | $0.875 | +357.14% | 1 | Mar 31, 2026 | |
| CLPT ClearPoint Neuro | Rated: Buy | $18 → $20 | $12.67 | +57.85% | 4 | Mar 18, 2026 | |
| XGN Exagen | Maintained: Buy | $8 | $4.98 | +60.64% | 4 | Mar 11, 2026 | |
| ANIK Anika Therapeutics | Maintained: Buy | $16 → $18 | $14.53 | +23.88% | 3 | Feb 26, 2026 | |
| SPOK Spok Holdings | Downgraded: Hold | $14 | $10.59 | +32.20% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.03 | +146.31% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $6.49 | +115.72% | 3 | Jan 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.07 | +32.30% | 2 | Nov 5, 2025 |
Varex Imaging
May 28, 2026
Reiterated: Buy
Price Target: $18
Current: $10.23
Upside: +75.95%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $3.91
Upside: +155.75%
Electromed
May 13, 2026
Maintained: Buy
Price Target: $38 → $40
Current: $37.72
Upside: +6.04%
OptimizeRx
May 13, 2026
Maintained: Buy
Price Target: $11 → $10
Current: $5.19
Upside: +92.68%
Tactile Systems Technology
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $24.61
Upside: +46.28%
HeartBeam
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.875
Upside: +357.14%
ClearPoint Neuro
Mar 18, 2026
Rated: Buy
Price Target: $18 → $20
Current: $12.67
Upside: +57.85%
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $8
Current: $4.98
Upside: +60.64%
Anika Therapeutics
Feb 26, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $14.53
Upside: +23.88%
Spok Holdings
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.59
Upside: +32.20%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $2.03
Upside: +146.31%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $6.49
Upside: +115.72%
Nov 5, 2025
Maintained: Buy
Price Target: $12
Current: $9.07
Upside: +32.30%